Exencial Wealth Advisors LLC decreased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 2.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 79,522 shares of the company’s stock after selling 2,004 shares during the quarter. Colgate-Palmolive comprises approximately 1.3% of Exencial Wealth Advisors LLC’s portfolio, making the stock its 16th biggest holding. Exencial Wealth Advisors LLC’s holdings in Colgate-Palmolive were worth $5,450,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Capital Financial Planning LLC bought a new stake in Colgate-Palmolive in the fourth quarter worth $27,000. Parisi Gray Wealth Management raised its stake in shares of Colgate-Palmolive by 365.3% during the fourth quarter. Parisi Gray Wealth Management now owns 470 shares of the company’s stock valued at $28,000 after acquiring an additional 369 shares during the last quarter. Timber Creek Capital Management LLC raised its stake in Colgate-Palmolive by 247.1% in the fourth quarter. Timber Creek Capital Management LLC now owns 472 shares of the company’s stock worth $28,000 after buying an additional 336 shares in the last quarter. Portfolio Solutions LLC bought a new position in Colgate-Palmolive in the fourth quarter worth about $30,000. Finally, WP Advisors LLC bought a new position in Colgate-Palmolive in the first quarter worth about $34,000. 74.63% of the stock is currently owned by institutional investors and hedge funds.
Shares of NYSE CL opened at $71.20 on Friday. Colgate-Palmolive has a 1 year low of $57.41 and a 1 year high of $73.10. The firm has a market cap of $61.13 billion, a P/E ratio of 23.97, a PEG ratio of 4.69 and a beta of 0.81. The company has a current ratio of 1.07, a quick ratio of 0.74 and a debt-to-equity ratio of 32.25.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, April 26th. The company reported $0.67 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.66 by $0.01. The company had revenue of $3.88 billion during the quarter, compared to analysts’ expectations of $3.86 billion. Colgate-Palmolive had a net margin of 15.08% and a negative return on equity of 3,730.37%. The firm’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.74 earnings per share. On average, research analysts anticipate that Colgate-Palmolive will post 2.83 EPS for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Friday, April 19th were issued a $0.43 dividend. The ex-dividend date was Wednesday, April 17th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.42%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.42. Colgate-Palmolive’s dividend payout ratio is currently 57.91%.
In other news, VP Philip G. Shotts sold 8,800 shares of the firm’s stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $71.66, for a total value of $630,608.00. Following the completion of the transaction, the vice president now owns 50,032 shares of the company’s stock, valued at $3,585,293.12. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Stephen I. Sadove sold 8,000 shares of the firm’s stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $71.55, for a total transaction of $572,400.00. Following the completion of the sale, the director now directly owns 39,441 shares in the company, valued at approximately $2,822,003.55. The disclosure for this sale can be found here. Insiders sold 335,211 shares of company stock valued at $23,724,495 in the last three months. 1.14% of the stock is currently owned by insiders.
CL has been the topic of a number of recent research reports. Jefferies Financial Group restated a “hold” rating and issued a $61.00 price objective on shares of Colgate-Palmolive in a report on Friday, February 1st. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 30th. BNP Paribas upgraded shares of Colgate-Palmolive from an “underperform” rating to a “neutral” rating and raised their target price for the stock from $56.00 to $67.00 in a report on Monday, February 11th. Wells Fargo & Co reiterated a “hold” rating and issued a $57.00 price target on shares of Colgate-Palmolive in a research report on Thursday, January 31st. Finally, Macquarie set a $57.00 price target on shares of Colgate-Palmolive and gave the stock a “hold” rating in a research report on Tuesday, January 29th. One investment analyst has rated the stock with a sell rating, twelve have assigned a hold rating and five have given a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $69.53.
ILLEGAL ACTIVITY NOTICE: This piece of content was published by Zolmax and is the sole property of of Zolmax. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The correct version of this piece of content can be read at https://zolmax.com/investing/exencial-wealth-advisors-llc-lowers-position-in-colgate-palmolive-cl/3095655.html.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Recommended Story: Understanding debt-to-equity ratio in fundamental analysis
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.